Pui Yee Ng - Concepedia

Author

Pui Yee Ng

Broad Institute

Also Known As

Jeremy S. Disch, Ng, Pui Yee, P. Ng, P. Y. NG, P.Y. NG, P.Y. Ng, Pui Ng, Pui Y. Ng, Pui Yee Ng, Pui Yee Ng

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Broad Institute The University of Melbourne Monash University The University of Queensland Peter MacCallum Cancer Centre

About

Pui Yee Ng is an author at Broad Institute specializing in medicine, pharmacology, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	2K
2	Engineering	6	6	350
3	Natural Sciences	5	5	221
4	Biomolecular Engineering	5	5	2K
5	Biochemistry	4	4	198

Pui Yee Ng

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes Jill C. Milne, Philip Lambert, Simon Schenk, Nature Diabetes ManagementMedicineDiabetesType 2Small Molecule Activators	2007	1.7K
AKT Promotes rRNA Synthesis and Cooperates with c-MYC to Stimulate Ribosome Biogenesis in Cancer Joanna C. Chan, Katherine M. Hannan, Kim Riddell, Science Signaling	2011	236
Crystallographic structure of a small molecule SIRT1 activator-enzyme complex Han Dai, April Case, Thomas V. Riera, Nature Communications	2015	197
Strained Silacycles in Organic Synthesis: A New Reagent for the Enantioselective Allylation of Aldehydes James W. A. Kinnaird, Pui Yee Ng, Katsumi Kubota, Journal of the American Chemical Society Enantioselective SynthesisEngineeringStrain-release Lewis AcidityOrganic ChemistryCatalysis	2002	177
Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma Jennifer R. Devlin, Katherine M. Hannan, Nadine Hein, Cancer Discovery	2015	125
Discovery of Imidazo[1,2- <i>b</i> ]thiazole Derivatives as Novel SIRT1 Activators Chi B. Vu, Jean E. Bemis, Jeremy S. Disch, Journal of Medicinal Chemistry	2009	117
Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators Jean E. Bemis, Chi B. Vu, Roger L. Xie, Bioorganic & Medicinal Chemistry Letters HeterocyclicMedicineChemistryHeterocycle ChemistryRelated Heterocyclic Analogs	2008	90
Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors Karen E. Sheppard, Carleen Cullinane, Katherine M. Hannan, European Journal of Cancer Ras/erk Pathway InhibitorsSelective Pi3k/mtorMedicinePharmacologySynergistic Inhibition	2013	87
REDUCTION OF ENDOTHELIAL AND SMOOTH MUSCLE DENSITY IN THE CORPORA CAVERNOSA OF THE STREPTOZOTOCIN INDUCED DIABETIC RAT Tatjana Burchardt, Martin Burchardt, J. KARDEN, The Journal of Urology	2000	83
Synthesis of Diverse Lactam Carboxamides Leading to the Discovery of a New Transcription‐Factor Inhibitor Pui Yee Ng, Yuchen Tang, Wendy M. Knosp, Angewandte Chemie International Edition New Transcription‐factor InhibitorMolecular BiologyChemical BiologyPharmaceutical ChemistryLactam Carboxamides	2007	73

Page 1